SUNNOVA ENERGY INTERNATIONAL (NOVA)

US86745K1043 - Common Stock

4.46  +0.2 (+4.69%)

After market: 4.46 0 (0%)

Fundamental Rating

1

Taking everything into account, NOVA scores 1 out of 10 in our fundamental rating. NOVA was compared to 21 industry peers in the Independent Power and Renewable Electricity Producers industry. Both the profitability and financial health of NOVA have multiple concerns. NOVA is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

NOVA had negative earnings in the past year.
NOVA had a negative operating cash flow in the past year.
In the past 5 years NOVA always reported negative net income.
NOVA had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -3.21%, NOVA is doing worse than 75.00% of the companies in the same industry.
NOVA has a Return On Equity of -23.23%. This is in the lower half of the industry: NOVA underperforms 75.00% of its industry peers.
Industry RankSector Rank
ROA -3.21%
ROE -23.23%
ROIC N/A
ROA(3y)-2.71%
ROA(5y)-4.39%
ROE(3y)-17.23%
ROE(5y)-20.87%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of NOVA (42.86%) is worse than 60.00% of its industry peers.
NOVA's Gross Margin has declined in the last couple of years.
NOVA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.88%
GM growth 5Y-8.9%

0

2. Health

2.1 Basic Checks

NOVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NOVA has more shares outstanding
The number of shares outstanding for NOVA has been increased compared to 5 years ago.
The debt/assets ratio for NOVA is higher compared to a year ago.

2.2 Solvency

NOVA has an Altman-Z score of 0.01. This is a bad value and indicates that NOVA is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.01, NOVA is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
A Debt/Equity ratio of 4.45 is on the high side and indicates that NOVA has dependencies on debt financing.
The Debt to Equity ratio of NOVA (4.45) is worse than 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.45
Debt/FCF N/A
Altman-Z 0.01
ROIC/WACCN/A
WACC4.44%

2.3 Liquidity

A Current Ratio of 0.86 indicates that NOVA may have some problems paying its short term obligations.
NOVA has a Current ratio (0.86) which is in line with its industry peers.
A Quick Ratio of 0.73 indicates that NOVA may have some problems paying its short term obligations.
NOVA's Quick ratio of 0.73 is on the low side compared to the rest of the industry. NOVA is outperformed by 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.73

5

3. Growth

3.1 Past

The earnings per share for NOVA have decreased strongly by -42.33% in the last year.
The Revenue has grown by 12.17% in the past year. This is quite good.
The Revenue has been growing by 47.17% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-42.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-84.91%
Revenue 1Y (TTM)12.17%
Revenue growth 3Y64.87%
Revenue growth 5Y47.17%
Sales Q2Q%18.6%

3.2 Future

The Earnings Per Share is expected to grow by 8.56% on average over the next years. This is quite good.
The Revenue is expected to grow by 18.27% on average over the next years. This is quite good.
EPS Next Y29.17%
EPS Next 2Y15.94%
EPS Next 3Y7.83%
EPS Next 5Y8.56%
Revenue Next Year12.82%
Revenue Next 2Y18.58%
Revenue Next 3Y18.93%
Revenue Next 5Y18.27%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

0

4. Valuation

4.1 Price/Earnings Ratio

NOVA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NOVA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.94%
EPS Next 3Y7.83%

0

5. Dividend

5.1 Amount

No dividends for NOVA!.
Industry RankSector Rank
Dividend Yield N/A

SUNNOVA ENERGY INTERNATIONAL

NYSE:NOVA (1/6/2025, 5:05:01 PM)

After market: 4.46 0 (0%)

4.46

+0.2 (+4.69%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)10-30 2024-10-30/amc
Earnings (Next)02-19 2025-02-19/amc
Inst Owners119.79%
Inst Owner Change-0.01%
Ins Owners1.89%
Ins Owner Change1.29%
Market Cap557.28M
Analysts76.25
Price Target10.17 (128.03%)
Short Float %29.59%
Short Ratio2.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.8%
Min EPS beat(2)-73.88%
Max EPS beat(2)87.49%
EPS beat(4)2
Avg EPS beat(4)-160%
Min EPS beat(4)-677.74%
Max EPS beat(4)87.49%
EPS beat(8)3
Avg EPS beat(8)-99.2%
EPS beat(12)4
Avg EPS beat(12)-75.09%
EPS beat(16)4
Avg EPS beat(16)-90.89%
Revenue beat(2)0
Avg Revenue beat(2)-2.44%
Min Revenue beat(2)-3.65%
Max Revenue beat(2)-1.23%
Revenue beat(4)0
Avg Revenue beat(4)-9.68%
Min Revenue beat(4)-19.05%
Max Revenue beat(4)-1.23%
Revenue beat(8)2
Avg Revenue beat(8)-1.93%
Revenue beat(12)4
Avg Revenue beat(12)4.7%
Revenue beat(16)6
Avg Revenue beat(16)3.22%
PT rev (1m)-8.51%
PT rev (3m)-22.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-32.61%
EPS NY rev (1m)-1.3%
EPS NY rev (3m)-19.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.16%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.69
P/FCF N/A
P/OCF N/A
P/B 0.31
P/tB 0.33
EV/EBITDA N/A
EPS(TTM)-3.06
EYN/A
EPS(NY)-2.23
Fwd EYN/A
FCF(TTM)-17.04
FCFYN/A
OCF(TTM)-2.26
OCFYN/A
SpS6.48
BVpS14.24
TBVpS13.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.21%
ROE -23.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.86%
FCFM N/A
ROA(3y)-2.71%
ROA(5y)-4.39%
ROE(3y)-17.23%
ROE(5y)-20.87%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.88%
GM growth 5Y-8.9%
F-Score4
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 4.45
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 769.62%
Cap/Sales 228%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.86
Quick Ratio 0.73
Altman-Z 0.01
F-Score4
WACC4.44%
ROIC/WACCN/A
Cap/Depr(3y)720.68%
Cap/Depr(5y)782.12%
Cap/Sales(3y)213.11%
Cap/Sales(5y)265.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-84.91%
EPS Next Y29.17%
EPS Next 2Y15.94%
EPS Next 3Y7.83%
EPS Next 5Y8.56%
Revenue 1Y (TTM)12.17%
Revenue growth 3Y64.87%
Revenue growth 5Y47.17%
Sales Q2Q%18.6%
Revenue Next Year12.82%
Revenue Next 2Y18.58%
Revenue Next 3Y18.93%
Revenue Next 5Y18.27%
EBIT growth 1Y-56.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year550.52%
EBIT Next 3Y97.91%
EBIT Next 5Y57.23%
FCF growth 1Y-81.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.84%
OCF growth 3YN/A
OCF growth 5YN/A